Your Shopping Cart Is Empty
| Report Code: A03589 | Mar 2020 | Pages: 165 | ||
| Tables: 111 | Charts: 43 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Blood Lancets Market
Request Now !The global blood lancets market size was valued at $901.30 million in 2018 and is expected to reach $1,849.30 million by 2026, registering a CAGR of 9.4% from 2019 to 2026.
Blood lancet is defined as a medical instrument which is similar to a scalpel and has a double-edged blade. The blade is used to puncture the skin to obtain blood samples, which are further used for diagnosis of several diseases such as diabetes hyperlipidemia and dyslipidemia. These lancets are widely used by diabetic patients to monitor their blood glucose level. Blood lancet is a disposable medical device that is used in capillary blood sampling. In addition, blood lancets finds their applications in home healthcare as well as in clinics or pathology labs to confirm individual’s blood group.
Significant increase in prevalence of chronic diseases such as diabetes, hyperlipidemia, and dyslipidemia, and rise in inclination toward home care diagnostics are the major factors driving the blood lancets market growth. In addition, surge in use of disposable blood lancets for painless diagnosis of blood sugar level, hemoglobin, fat level, and other essential blood components propels the market growth. Disposable lancet prevents the risk of blood transfusion and infection transmission, which is thereby contributing to the blood lancets market growth. However, low awareness regarding homecare lancet in developing countries is anticipated to hamper the market growth. On the contrary, promising regulatory scenario positively impacts the blood lancets market growth, thereby, creating lucrative opportunities in the near future.
Global Blood Lancets Market Segmentation
The blood lancets market is segmented on the basis of type, end-user, and region. By type, it is segmented into standard, safety blood lancets and vacuum blood lancets. Based on end user, it is classified into hospitals & clinics, blood banks, homecare and others. Region wise, it is analyzed across North America (the U.S., Canada and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).
Type segment review
On the basis of type, it is segmented into standard, safety blood lancets and vacuum blood lancets and the safety blood lancets segment accounted for 41% of the share in 2018. Furthermore, it is also expected to exhibit a prominent growth rate in the near future, owing to its increased usage by the patients suffering with diabetes to monitor self-monitor their blood sugar level. Furthermore, blood banks make usage of sterile blood lancets to perform blood testing protocols prior collecting the blood from an individual. Thus, the factors aforementioned contribute to the growth of the blood lancets market.
End User segment review
Based on end user, the homecare segment dominated the blood lancets market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to significant increase in preference among patients toward homecare diagnosis of various chronic disease such as diabetes. Furthermore, the simple design and ease of use associated with blood lancets makes them an ideal device for self-diagnostics and diabetes monitoring. Thus, the factors aforementioned contribute to the growth of the market.
North America accounted for a major market share in 2018 and is anticipated to continue this trend during the forecast period. This is attributed to vigorous use and ease of availability of blood lancets in this region. In addition, the incidence of diabetes is increasing at a considerable rate in the U.S. For instance, according to the Center for Disease Control and Prevention, more than 100 million U.S. adults are now living with diabetes or prediabetes. Diabetes was the seventh leading cause of death in the U.S. in 2015. However, Asia-Pacific is anticipated to experience rapid growth during the forecast period, owing to rise in incidence of diabetes, high cholesterol, and other chronic disease. Moreover, an increase in demand for advanced healthcare services in the emerging economies such as India and China, is the major factor driving the growth of the Asia-Pacific blood lancets market. Thus, the factors aforementioned contribute to global blood lancets market growth in the region.
Comprehensive competitive analysis and profiles of major market players such as Becton, Dickinson & Company, Improve Medical, Terumo Corporation, Sarstedt AG & Co., F.L. Medical SRL, Medtronic plc, Haemonetics Corporation, Shangdong Lianfa Medical, Nipro Medical Corporation and Abbott Laboratories have been provided in this report.
Blood Lancets Market Report Highlights
| Aspects | Details |
|---|---|
| By Type |
|
| By End User |
|
| By Region |
|
| Key Market Players | Improve Medical (Guangzhou Improve Medical Instruments Co., Ltd), Nipro Medical Corporation, Sarstedt AG & CO., Medtronic Plc., Terumo corporation., Owen Mumford, Abbott Laboratories., Becton Dickinson And Company, SteriLance Medical, F L Medical S.R.L |
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Research methodology
1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Porter's five forces analysis
3.3. Top player positioning
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in incidence of chronic diseases
3.4.1.2. Rise in reimbursement policies
3.4.2. Restraint
3.4.2.1. Lack of patient awareness regarding blood lancets
3.4.3. Opportunity
3.4.3.1. Opportunity in developing economies
CHAPTER 4: BLOOD LANCETS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast, by type
4.2. Standard
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Safety Blood Lancets
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Vacuum Blood Lancets
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: BLOOD LANCET MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast, by end user
5.2. Hospitals & Clinics
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Blood Banks
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Homecare
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
CHAPTER 6: BLOOD LANCET MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. market size and forecast, by type
6.2.2.1.2. U.S. market size and forecast, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada market size and forecast, by type
6.2.2.2.2. Canada market size and forecast, by end user
6.2.2.3. Mexico
6.2.2.3.1. Mexico market size and forecast, by type
6.2.2.3.2. Mexico market size and forecast, by end user
6.2.3. Market size and forecast, by type
6.2.4. Market size and forecast, by end user
6.3. Europe
6.3.1. Key market trends
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany market size and forecast, by type
6.3.2.1.2. Germany market size and forecast, by end user
6.3.2.2. France
6.3.2.2.1. France market size and forecast, by type
6.3.2.2.2. France market size and forecast, by end user
6.3.2.3. UK
6.3.2.3.1. UK market size and forecast, by type
6.3.2.3.2. UK market size and forecast, by end user
6.3.2.4. Italy
6.3.2.4.1. Italy market size and forecast, by type
6.3.2.4.2. Italy market size and forecast, by end user
6.3.2.5. Rest of Europe
6.3.2.5.1. Rest of Europe market size and forecast, by type
6.3.2.5.2. Rest of Europe market size and forecast, by end user
6.3.3. Market size and forecast, by type
6.3.4. Market size and forecast, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan market size and forecast, by type
6.4.2.1.2. Japan market size and forecast, by end user
6.4.2.2. China
6.4.2.2.1. China market size and forecast, by type
6.4.2.2.2. China market size and forecast, by end user
6.4.2.3. India
6.4.2.3.1. India market size and forecast, by type
6.4.2.3.2. India market size and forecast, by end user
6.4.2.4. Rest of Asia-Pacific
6.4.2.4.1. Rest of Asia-Pacific market size and forecast, by type
6.4.2.4.2. Rest of Asia-Pacific market size and forecast, by end user
6.4.3. Market size and forecast, by type
6.4.4. Market size and forecast, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil market size and forecast, by type
6.5.2.1.2. Brazil market size and forecast, by end user
6.5.2.2. South Africa
6.5.2.2.1. South Africa market size and forecast, by type
6.5.2.2.2. South Africa market size and forecast, by end user
6.5.2.3. Saudi Arabia
6.5.2.3.1. Saudi Arabia market size and forecast, by type
6.5.2.3.2. Saudi Arabia market size and forecast, by end user
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA market size and forecast, by type
6.5.2.4.2. Rest of LAMEA market size and forecast, by end user
6.5.3. Market size and forecast, by type
6.5.4. Market size and forecast, by end user
CHAPTER 7: COMPANY PROFILES
7.1. Abbott Laboratories.
7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Product portfolio
7.1.4. Business performance
7.2. Becton Dickinson And Company
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. F L Medical S.R.L
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.4. Improve Medical (Guangzhou Improve Medical Instruments Co., Ltd)
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. Nipro Medical Corporation
7.5.1. Company overview
7.5.2. Operating business segments
7.5.3. Product portfolio
7.5.4. Business performance
7.6. Medtronic Plc.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Owen Mumford
7.7.1. Company overview
7.7.2. company Snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.8. Sarstedt AG & CO.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.9. SteriLance Medical
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.10. Terumo corporation.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
LIST OF TABLES
TABLE 01. GLOBAL BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 02. STANDARD BLOOD LANCETS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03. STANDARD MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 04. SAFETY BLOOD LANCETS MARKET BY REGION 2018–2026 ($MILLION)
TABLE 05. SAFETY BLOOD LANCETS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 06. VACUUM BLOOD LANCETS MARKET BY REGION 2018–2026 ($MILLION)
TABLE 07. VACUUM BLOOD LANCETS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 08. GLOBAL BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 09. BLOOD LANCET MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018–2026 ($MILLION)
TABLE 10. GOLD BLOOD LANCET MARKET, FOR BLOOD BANKS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. GOLD BLOOD LANCET MARKET, FOR HOMECARE, BY REGION, 2018–2026 ($MILLION)
TABLE 12. SILVER BLOOD LANCET MARKET, FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 13. BLOOD LANCET MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA BLOOD LANCETS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 15. U.S. BLOOD LANCETS MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 16. U.S. BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 17. CANADA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 18. CANADA BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 19. MEXICO BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 20. MEXICO BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 21. NORTH AMERICA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 22. NORTH AMERICA BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 23. EUROPE BLOOD LANCETS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 24. GERMANY BLOOD LANCETS MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 25. GERMANY BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 26. FRANCE BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 27. FRANCE BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 28. UK BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 29. UK BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 30. ITALY BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 31. ITALY BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 32. REST OF EUROPE BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 33. REST OF EUROPE BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 34. EUROPE BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 35. EUROPE BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 36. EUROPE BLOOD LANCETS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 37. JAPAN BLOOD LANCETS MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 38. JAPAN BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 39. CHINA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 40. CHINA BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 41. INDIA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 42. INDIA BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 43. REST OF ASIA-PACIFIC BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 44. REST OF ASIA-PACIFIC BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 45. ASIA-PACIFIC BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 46. ASIA-PACIFIC BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 47. EUROPE BLOOD LANCETS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 48. BRAZIL BLOOD LANCETS MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 49. BRAZIL BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 50. SOUTH AFRICA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 51. SOUTH AFRICA BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 52. SAUDI ARABIA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 53. SAUDI ARABIA BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 54. REST OF LAMEA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 55. REST OF LAMEA BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 56. LAMEA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 57. LAMEA BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 58. ABBOTT: COMPANY SNAPSHOT
TABLE 59. ABBOTT: OPERATING SEGMENTS
TABLE 60. ABBOTT: PRODUCT PORTFOLIO
TABLE 61. BECKTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 62. BECKTON DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 63. BECKTON DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 64. F L: COMPANY SNAPSHOT
TABLE 65. F L: OPERATING SEGMENT
TABLE 66. F L: PRODUCT PORTFOLIO
TABLE 67. IMPROVE MEDICAL: COMPANY SNAPSHOT
TABLE 68. IMPROVE MEDICAL: PRODUCT SEGMENTS
TABLE 69. IMPROVE MEDICAL: PRODUCT PORTFOLIO
TABLE 70. NIPRO: COMPANY SNAPSHOT
TABLE 71. NIPRO : OPERATING SEGMENTS
TABLE 72. NIPRO: PRODUCT PORTFOLIO
TABLE 73. MEDTRONIC: COMPANY SNAPSHOT
TABLE 74. MEDTRONIC: OPERATING SEGMENTS
TABLE 75. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 76. OWEN: COMPANY SNAPSHOT
TABLE 77. OWEN: PRODUCT PORTFOLIO
TABLE 78. SARSTEDT: COMPANY SNAPSHOT
TABLE 79. SARSTEDT: OPERATING SEGMENTS
TABLE 80. SARSTEDT: PRODUCT PORTFOLIO
TABLE 81. STERILANCE: COMPANY SNAPSHOT
TABLE 82. STERILANCE: OPERATING SEGMENTS
TABLE 83. STERILANCE: PRODUCT PORTFOLIO
TABLE 84. TERUMO.: COMPANY SNAPSHOT
TABLE 85. TERUMO.: OPERATING SEGMENTS
TABLE 86. TERUMO.: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. GLOBAL BLOOD LANCETS MARKET SEGMENTATION
FIGURE 02. LOW-TO- MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 03. LOW BARGAINING POWER OF BUYER
FIGURE 04. MODERATE THREAT OF SUBSTITUTES
FIGURE 05. LOW-TO-MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. HIGH COMPETITIVE RIVALARY
FIGURE 07. TOP PLAYER POSITIONING, 2018
FIGURE 08. DRIVERS AND RESTRAINTS
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF BLOOD LANCET MARKET, FOR HOSPITALS & CLINICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF BLOOD LANCET MARKET, FOR BLOOD BANKS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF BLOOD LANCET MARKET, FOR HOMECARE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF BLOOD LANCET MARKET, FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. U.S. BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 14. CANADA BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 15. MEXICO BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 16. GERMANY BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 17. FRANCE BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 18. UK BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 19. ITALY BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 20. REST OF EUROPE BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 21. JAPAN BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 22. CHINA BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 23. INDIA BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 24. REST OF ASIA-PACIFIC BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 25. BRAZIL BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 26. SOUTH AFRICA BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 27. SAUDI ARABIA BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 28. REST OF LAMEA BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 29. ABBOTT LABORATORIES: NET SALES, 2016–2018 ($MILLION)
FIGURE 30. ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 31. ABBOTT: REVENUE SHARE BY REGION, 2018(%)
FIGURE 32. BECKTON DICKINSON AND COMPANY: NET SALES, 2016–2018 ($MILLION, 2018 (%)
FIGURE 33. BECKTON DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 34. BECKTON DICKINSON AND COMPANY: REVENUE SHARE BY REGION,2018%
FIGURE 35. NIPRO: NET SALES, 2016–2018 ($MILLION)
FIGURE 36. NIPRO: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 37. NIPRO: REVENUE SHARE BY REGION, 2018(%)
FIGURE 38. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 39. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 40. MEDTRONIC: REVENUE SHARE BY REGION 2018 (%)
FIGURE 41. TERUMO, 2016–2018 ($MILLION)
FIGURE 42. TERUMO: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 43. TERUMO : REVENUE SHARE BY REGION, BY 2018%
Blood lancets are disposable medical devices and are frequently being used in hospitals, clinics, and diagnostic laboratories for obtaining blood and performing various tests. Blood collected through the lancet can be used for disease diagnosis including, cholesterol monitoring, diabetes, and various others. Blood lancets find their applications in home healthcare as well as in clinics or pathology labs to confirm individuals blood group.
Moreover, the blood lancets market is anticipated to witness steady growth in future, owing to rise in incidence of diabetes across the globe and upsurge in usage of homecare medical devices. However, low awareness among individuals in developing economies regarding the usage of blood lancets is expected to hamper the market growth in near future. On the contrary, technological advancements pertaining to the development of homecare devices is anticipated to create lucrative opportunities in the near future.
A. The total market value of blood lancets market is $901 million in 2018.
A. The forcast period for blood lancets market is 2019 to 2026
A. The market value of blood lancets market in 2019 is $1,849 million
A. The base year is 2018 in blood lancets market
A. Top companies such as, Becton Dickinson And Company, Medtronic Plc, Abbott laboratories, Nipro Medical Corporation held a high market position in 2018. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. Safety blood lancets segment is the most influencing segment growing in the blood lancets market owing to benefits associated with their use. For instance, these lancets are retractable needles which avert accidental pricks and eliminate risk of contamination.
A. The key trend in the blood lancets market is the rise in incidence of chronic diseases such as diabetes, high cholesterol, and others. This leads to surge in the demand for blood lancets which boots the growth of the market.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as India with a CAGR of 10.5%. This is due to surge in prevelance of chronic disorders such as diabetes in the region.
A. Blood lancet is a disposable medical device mainly used to make minuscule punctures in the skin to obtain blood samples. There are different types of blood lancets present in the market such as safety blood lancets, vacuum blood lancets and others.
A. Blood lancets are used to obtain blood samples, which are further used for diagnosis of several diseases such as diabetes hyperlipidemia and dyslipidemia. These lancets are widely used by diabetic patients to monitor their blood glucose level.
Start reading instantly.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report